Wakefield Asset Management LLLP Makes New $861,000 Investment in Azenta, Inc. (NASDAQ:AZTA)

Wakefield Asset Management LLLP acquired a new stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 24,851 shares of the company's stock, valued at approximately $861,000. Wakefield Asset Management LLLP owned approximately 0.05% of Azenta at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in AZTA. Dimensional Fund Advisors LP lifted its position in shares of Azenta by 0.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,033,171 shares of the company's stock valued at $151,659,000 after acquiring an additional 26,929 shares in the last quarter. Conestoga Capital Advisors LLC lifted its position in shares of Azenta by 21.4% in the 1st quarter. Conestoga Capital Advisors LLC now owns 1,915,556 shares of the company's stock valued at $66,355,000 after acquiring an additional 337,675 shares in the last quarter. Schroder Investment Management Group lifted its position in shares of Azenta by 46.7% in the 4th quarter. Schroder Investment Management Group now owns 1,405,056 shares of the company's stock valued at $70,183,000 after acquiring an additional 447,292 shares in the last quarter. Lord Abbett & CO. LLC purchased a new stake in Azenta in the 4th quarter worth approximately $47,350,000. Finally, Palisade Capital Management LP lifted its position in Azenta by 7.1% in the 1st quarter. Palisade Capital Management LP now owns 868,324 shares of the company's stock worth $30,079,000 after buying an additional 57,418 shares in the last quarter. 99.08% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

AZTA has been the subject of a number of research analyst reports. Stephens started coverage on shares of Azenta in a research report on Tuesday, July 22nd. They issued an "equal weight" rating and a $35.00 target price for the company. Needham & Company LLC dropped their price target on shares of Azenta from $59.00 to $40.00 and set a "buy" rating on the stock in a research note on Wednesday, May 7th. Finally, Evercore ISI increased their price target on shares of Azenta from $29.00 to $35.00 and gave the stock an "in-line" rating in a research note on Tuesday, July 8th.

Azenta Stock Up 1.4%

Shares of AZTA traded up $0.47 during mid-day trading on Friday, hitting $34.43. 437,863 shares of the company's stock were exchanged, compared to its average volume of 952,662. Azenta, Inc. has a twelve month low of $23.91 and a twelve month high of $63.58. The firm has a fifty day moving average of $30.35 and a two-hundred day moving average of $35.82. The stock has a market cap of $1.58 billion, a price-to-earnings ratio of -24.77 and a beta of 1.64.

Azenta (NASDAQ:AZTA - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a positive return on equity of 1.30% and a negative net margin of 10.31%. The business's revenue for the quarter was up 5.1% compared to the same quarter last year. During the same quarter last year, the business earned $0.06 earnings per share. On average, equities analysts predict that Azenta, Inc. will post 0.53 earnings per share for the current year.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.